DP3 Stock Overview
Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Central Pharmaceutical Joint Stock Company No3 Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫63,500.00 |
| 52 Week High | ₫77,000.00 |
| 52 Week Low | ₫57,500.00 |
| Beta | 0.32 |
| 11 Month Change | 1.60% |
| 3 Month Change | -3.93% |
| 1 Year Change | -6.62% |
| 33 Year Change | 34.53% |
| 5 Year Change | 144.23% |
| Change since IPO | 655.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| DP3 | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -1.9% | -2.7% | -2.9% |
| 1Y | -6.6% | 11.6% | 2.1% |
Return vs Industry: DP3 underperformed the VN Pharmaceuticals industry which returned 9.1% over the past year.
Return vs Market: DP3 underperformed the VN Market which returned 2.2% over the past year.
Price Volatility
| DP3 volatility | |
|---|---|
| DP3 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in VN Market | 7.9% |
| 10% least volatile stocks in VN Market | 2.8% |
Stable Share Price: DP3 has not had significant price volatility in the past 3 months.
Volatility Over Time: DP3's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | n/a | www.duocphamtw3.com |
Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. It offers medicines from medicinal herbs, western medicines2, functional foods, and cosmetics products. Central Pharmaceutical Joint Stock Company No3 was founded in 1962 and is based in H
Central Pharmaceutical Joint Stock Company No3 Fundamentals Summary
| DP3 fundamental statistics | |
|---|---|
| Market cap | ₫1.37t |
| Earnings (TTM) | ₫119.19b |
| Revenue (TTM) | ₫395.21b |
11.5x
P/E Ratio3.5x
P/S RatioIs DP3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DP3 income statement (TTM) | |
|---|---|
| Revenue | ₫395.21b |
| Cost of Revenue | ₫126.63b |
| Gross Profit | ₫268.58b |
| Other Expenses | ₫149.39b |
| Earnings | ₫119.19b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.54k |
| Gross Margin | 67.96% |
| Net Profit Margin | 30.16% |
| Debt/Equity Ratio | 0% |
How did DP3 perform over the long term?
See historical performance and comparison